ProterixBio Presents Results from Multiple COPD Clinical Studies at the American Thoracic Society International Conference
Billerica MA, May 22, 2018 – ProterixBio, Inc. today announced that results from three clinical studies of subjects with chronic obstructive pulmonary disease (COPD) were presented at the American Thoracic Society International Conference this week. One presentation, “Prospective Evaluation of Algorithms Based on Blood Biomarkers as Guides for COPD Assessment and Risk Stratification,” highlighted that… Read more »
ProterixBio presents COPD clinical study results at the European Respiratory Society International Congress
Billerica MA, September 12, 2017 – ProterixBio, Inc. today announced that results from a recent clinical study of subjects with chronic obstructive pulmonary disease (COPD) were presented this week at the European Respiratory Society International Congress. Algorithms based on combinations of protein biomarkers were successfully associated with measures of COPD disease activity such as shortness… Read more »
ProterixBio Joins the Industrial Advisory Boards of the COPD Foundation and the SPIROMICS Consortium
Billerica, MA, September 13, 2016 – ProterixBio, Inc. today announced that it has joined the Industrial Advisory boards of the COPD (chronic obstructive pulmonary disease) Foundation and the SPIROMICS Consortium. Joining both advisory boards reflects ProterixBio’s commitment to develop novel clinical applications including diagnostics products and disease management tools for pulmonary diseases. ProterixBio is developing… Read more »